Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker

OBJECTIVE: Blood tests to monitor disease activity, attack severity, or treatment impact in neuromyelitis optica spectrum disorder (NMOSD) have not been developed. This study investigated the relationship between serum glial fibrillary acidic protein (sGFAP) concentration and NMOSD activity and asse...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Neurol
Auteurs principaux: Aktas, Orhan, Smith, Michael A., Rees, William A., Bennett, Jeffrey L., She, Dewei, Katz, Eliezer, Cree, Bruce A. C.
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2021
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252046/
https://ncbi.nlm.nih.gov/pubmed/33724534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.26067
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires